✦ LIBER ✦

Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

✍ Scribed by Ginna G. Laport; Kevin Sheehan; Jeanette Baker; Randall Armstrong; Ruby M. Wong; Robert Lowsky; Laura J. Johnston; Judith A. Shizuru; David Miklos; Sally Arai; Jonathan E. Benjamin; Wen-Kai Weng; Robert S. Negrin

Book ID: 116282680
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 470 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.05.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic peripheral blood hematopoieti

Allogeneic peripheral blood hematopoietic stem cell transplantation for patients with hematologic malignancies

✍ Xia Linghui; Fang Jun; You Yong; Guo Tao; Liu Fang; Zhang Chun; Jiang Huijuan; Z 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 Chinese ⚖ 308 KB

Cytokine induced killer cells as adoptiv

Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation

✍ Sangiolo, D; Mesiano, G; Carnevale-Schianca, F; Piacibello, W; Aglietta, M; Cign 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 474 KB

Outcomes among Patients with Recurrent H

Outcomes among Patients with Recurrent High-Risk Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

✍ Marco Mielcarek; Barry E. Storer; Mary E.D. Flowers; Rainer Storb; Brenda M. San 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Adoptive immunotherapy with tumor-derive

Adoptive immunotherapy with tumor-derived donor lymphocytes after allogeneic hematopoietic stem cell transplantation

✍ N.M. Hardy; V. Fellowes; J. Mariotti; C. Carter; C. June; B. Levine; F. Hakim; R 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Immunomodulatory strategies for relapse

Immunomodulatory strategies for relapse after haploidentical hematopoietic stem cell transplantation in hematologic malignancy patients

✍ Xiao-Jun Huang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Predictive Factors for Adverse Outcomes

Predictive Factors for Adverse Outcomes After Use of Donor Cell Infusion (DCI) in Patients with Relapsed Hematological Malignancies Treated with Allogeneic Hematopoietic Cell Transplantation (alloHCT)

✍ N. Bejanyan; B. Bolwell; L. Rybicki; D. Abounader; H. Duong; R. Dean; R. Sobecks 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB